Navigation Links
Insmed Provides Update on Supply of IPLEX(TM)
Date:7/27/2009

r ALS patients in the U.S. that had been discussed with FDA earlier this year has been postponed while the Company performs this assessment.

Dr. Melvin Sharoky, Insmed's Chairman, said, "We believe that it is in the best interests of patients who are currently receiving IPLEX(TM) to ensure that our current limited inventory is conserved in order to maintain their drug supply as long as possible, while allowing the Company time to consider its development options."

About Insmed

Insmed Inc. is a biopharmaceutical company with unique protein development experience and a proprietary protein platform aimed at niche markets with unmet medical needs. For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to the existing supply of IPLEX(TM) and possible production of additional quantities of IPLEX(TM) by third party manufacturers, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, the available supply of IPLEX(TM) may be used more quickly than expected; we may decide not to pursue a third party manufacturing arrangement for IPLEX(TM); if we decide to pursue such a manufacturing arrangement, we may not be able to find a third party manufacturer willing to produce IPLEX(TM) or be able to negotiate acceptable terms; it may take any third party manufacturer more time than expected to successfully begin producing n
'/>"/>

SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
2. Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND
3. Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants
4. Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs
5. Insmed to Present at Upcoming Healthcare Conferences
6. Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
7. President Obamas Visit to Cleveland Clinic Provides Look at High-Quality, Cost-Effective Healthcare Delivery Model
8. Study provides documentation that tumor stem-like cells exist in benign tumors
9. Align Technology Provides Update on Patent Litigation with Ormco Corporation
10. International Isotopes Inc. Announces Results of the Annual Meeting and Provides an Update on its Depleted Uranium Processing and Fluorine Extraction Process Plant
11. Leading Los Angeles Clinic (laserandveinclinic.com) Provides Top Notch Aesthetic Laser Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 05, 2015 In recognition of its ... patients, Soho Flordis International (SFI) has been honored by ... a global natural medicine company committed to identifying and ... quality, safety, and effectiveness. For these efforts the non-profit ... Commercial Investment in Phytomedicinal Research Award. , Phytomedicinal ...
(Date:3/5/2015)... 05, 2015 The Shaolin Chan Foundation ... and Wellness at Atlanta Shaolin Institute along with Grandmaster ... Industrial BLVD, Suite 500A, city of Peachtree Corners, Georgia. ... which is a non-profit organization that promotes natural, healthy ... medicine. , The seminar was well received by ...
(Date:3/4/2015)... 05, 2015 Understanding China’s New Medical ... p.m. – 3:00 p.m. EDT, http://www.fdanews.com/UnderstandingChinaMDRegs , ... regulations for medical devices in China. , These ... — research and development, approval, manufacturing, distribution, and post-market ... currently in development as well as those that are ...
(Date:3/4/2015)... The Asia-Pacific phthalic anhydride market is estimated to ... at a CAGR of 5.9% during the forecast ... the TOC of Asia-Pacific Phthalic Anhydride Market for ... the help of various tables and figures., ... derivative of phthalic acid, which is either obtained ...
(Date:3/4/2015)... 04, 2015 The federal litigation established ... statin drug caused patients to develop Type 2 diabetes ... District of South Carolina. According to court documents, the ... 26, 2015 at 10:00 a.m. In advance of the ... Joint Status report to the Court by March 19, ...
Breaking Medicine News(10 mins):Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 2Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 3Health News:Top Martial Arts Master Wu Bin of China, Has Successfully Conducted a Time-Honored Kung Fu Seminar for Health & Wellness at Shaolin Institute, Atlanta, GA 2Health News:Top Martial Arts Master Wu Bin of China, Has Successfully Conducted a Time-Honored Kung Fu Seminar for Health & Wellness at Shaolin Institute, Atlanta, GA 3Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 2Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 3Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 2Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 3Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3
... OFFER CCHIT MANDATED FEATURESLOS ANGELES, April 20 ... Board: FVRL), which through its wholly-owned operating ... Personal Health Records ("PHRs") ( www.mymedicalrecords.com ... storage solutions ( www.myesafedepositbox.com ), ...
... Medarex, Inc. (Nasdaq: MEDX ) today ... trial of MDX-1401 in patients with relapsed or refractory ... activity signals. MDX-1401 is a fully human, non-fucosylated ... that is present on malignant cells of HL as ...
... 20 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, ... the three-month period ended March 31, 2009. First ... compared to $1.173 million for the same period ... any quarter in the Company,s history and, as ...
... Mix Featuring Arthur and Friends , BURLINGTON, Mass. ... Cherrybrook Kitchen, the brand known for allergy-friendly desserts and ... Arthur, the award-winning PBS character whose TV show entertains ... challenges, lessons and obstacles of growing up. Launched in ...
... The Leukemia & Lymphoma SocietyWHITE PLAINS, N.Y., April 20 ... mothers perform on behalf of their children and other loved ... something special to pay tribute to mothers.Consider the heroic gesture ... nothing more terrifying for a mother than to watch helplessly ...
... today by Dystonia Medical Research Foundation: WHAT: ... the Dystonia , Medical Research Foundation (DMRF) -- ... for Dystonia (a "poker run" primarily for motorcyclists), a fundraiser ... this rare, but disabling, neurological disorder.In 2005, Debbi Mack published ...
Cached Medicine News:Health News:MMR Information Systems, Inc. Announces 250,000 Membership Milestone and Granting of International Patents 2Health News:MMR Information Systems, Inc. Announces 250,000 Membership Milestone and Granting of International Patents 3Health News:MMR Information Systems, Inc. Announces 250,000 Membership Milestone and Granting of International Patents 4Health News:MMR Information Systems, Inc. Announces 250,000 Membership Milestone and Granting of International Patents 5Health News:Medarex Announces Clinical Data for MDX-1401 in Hodgkin's Lymphoma at Annual Meeting of the American Association for Cancer Research 2Health News:Medarex Announces Clinical Data for MDX-1401 in Hodgkin's Lymphoma at Annual Meeting of the American Association for Cancer Research 3Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 2Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 3Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 4Health News:Cherrybrook Kitchen Announces New Partnership With Arthur 2Health News:Cherrybrook Kitchen Announces New Partnership With Arthur 3Health News:This Mother's Day Celebrate a Mother's Love 2Health News:Maryland Mystery Author Organizes Fundraising Ride for Rare Neurological Disorder 2
(Date:3/4/2015)... NEW YORK , March 4, 2015 /PRNewswire/ ... orthopedic device market is the increasing elderly population, ... in a recent report from the healthcare market ... aging population coupled with other risk factors such ... orthopedic incidence worldwide. Demand for innovative product designs ...
(Date:3/4/2015)... March 4, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... the t:slim® and t:flex™ Insulin Pumps, today announced the closing ... of common stock at a price to the public of ... the underwriters of their option to purchase up to an ... were offered by Tandem. BofA Merrill Lynch ...
(Date:3/4/2015)... March 4, 2015 Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, today announced that Pedro ... The Opening Bell ® of the New York ... began trading as an NYSE MKT listed company on ... Exchange is a trusted partner to Asterias Biotherapeutics, and ...
Breaking Medicine Technology:Kalorama: Growing Elderly Population Drives Orthopedic Device Market 2Kalorama: Growing Elderly Population Drives Orthopedic Device Market 3Tandem Diabetes Care Announces Closing of Underwritten Public Offering of Common Stock 2Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 2Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 3
... 2011 A free white paper that guides manufacturers ... processes is available from Microtest Laboratories. It is available ... many medical devices are made of high-tech materials such ... the use of various agents to aid in the ...
... CHICAGO and SAN DIEGO, June 6, 2011 ... TG01) in combination with erlotinib demonstrated significant and ... clinically relevant subset of biomarker-selected patients with non-small ... a platinum-containing regimen for advanced disease. Complete data ...
Cached Medicine Technology:New White Paper Helps Medical Device Manufacturers Validate Cleaning Processes 2Apricoxib Prolongs Time-to-Progression and Overall Survival in Biomarker-Selected NSCLC Patients 2Apricoxib Prolongs Time-to-Progression and Overall Survival in Biomarker-Selected NSCLC Patients 3Apricoxib Prolongs Time-to-Progression and Overall Survival in Biomarker-Selected NSCLC Patients 4
... 2000 is designed to monitor, store and measure ... (stress-testing). The system can organize the amount of ... for a quick review and printout of an ... is transmitted via a small portable ECG recorder ...
... Burdick ExTOL systems feature your choice ... multi-channel electrocardiographs, an easy-to-operate monitor and ... ExTOL exercise stress testing systems also ... measurement point, pre-programmed or custom protocols, ...
... w/ Remote/Controller. Includes Full Range ... Children. Multiple 20/20 slides. Polarized ... allows you to customize your slide choices. ... with Long Life. Variety of mounting options. ...
... The Ultimate in ... Octopus 4.3 stabilizer features ... unmatched stability in the ... 4.3 Stabilizer features the ...
Medicine Products: